The effect of magnesium on maternal blood pressure in pregnancy-induced hypertension. A randomized double-blind placebo-controlled trial.

What Was Tested

Researchers studied Magnesium in the context of low blood pressure and orthostatic hypotension in this randomized controlled trial publication.

The effects of magnesium were compared with those of placebo in a randomized double-blind controlled study of 58 patients with pregnancy-induced hypertension, of whom 27 received magnesium and 31 placebo.

Twenty patients in each group were nulliparas.

Who Took Part

According to the abstract, 58 patients were involved.

The age groups tagged for this paper are adults, women only.

How the Study Was Run

The design is described as randomized, double-blind and placebo-controlled.

Because people in this Magnesium study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Blinding on both sides kept the patients and researchers unaware of who received Magnesium.

Some patients received a placebo instead of Magnesium, giving a reference point.

What Was Measured

Topics PubMed links to this paper include Birth Weight, Blood Pressure, Hypertension, Magnesium and Pregnancy Complications, Cardiovascular.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Magnesium in 58 patients in people with low blood pressure and orthostatic hypotension.

The publication is from 1991 (Acta obstetricia et gynecologica Scandinavica), a journal based in United States.

More context: the related Vitamin D, K2, Magnesium and Zinc library page, Low blood pressure and orthostatic hypotension research.